Standout Papers

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy 2024 202676
  1. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy (2024)
    Mark Hamilton, Takeshi Sugio et al. New England Journal of Medicine

Citation Impact

9 by Nobel laureates 34 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Co-opting signalling molecules enables logic-gated control of CAR T cells
2023 StandoutNature
CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
2 intermediate papers

Works of Bita Sahaf being referenced

Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells
2019
Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies
2018
and 1 more

Author Peers

Author Immunology Molecular Biology Oncology Last Decade Papers Cites
Bita Sahaf 987 1183 485 62 2.7k
R. Rey 35 907
A. H. Fowler 9 54 4 7 454
LuAnn Wandsnider 5 20 506
Wayne C. Myrvold 18 1 37 569
Emily Wyman 1 13 810

All Works

Loading papers...

Rankless by CCL
2026